Condition
Renal Cancers
Total Trials
2
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Cryoablation
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 2 (2)
Trial Status
Active Not Recruiting1
Withdrawn1
Clinical Trials (2)
Research Network
Common Treatments
- Cryoablation1
- Stereotactic Ablative Radiation Therapy1
- Radiofrequency Ablation1
Active Sponsors
- St. Joseph's Healthcare Hamilton1
- University of Texas Southwestern Medical Center1
Top Investigators
McMaster Institute of Urology, McMaster University
UTSW